DHouseRepresentative · California

Bought up to $15,000 of Ultragenyx Pharmaceutical (RARE)

Name: Gilbert Ray Cisneros Jr. bought $15,000 of Ultragenyx Pharmaceutical
Creator: Capitol Markets

Trade dated Feb 18, 202619 days to disclose

RARE since the buy

+14.0%

S&P 500, same window

+10.3%

▲ RARE beat the S&P 500 by 3.7 points since the buy

Price move from the trade date's close to the most recent close. A buy is favorable when the stock rose after.

On the public record around this trade

Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.

Dec 17, 2025Floor vote
Voted Yea on Lower Health Care Premiums for All Americans Act
Result: Failed
Dec 17, 2025Floor vote
Voted Nay on Lower Health Care Premiums for All Americans Act
Result: Passed
Dec 18, 2025Floor vote
Voted Yea on Do No Harm in Medicaid Act
Result: Failed
Dec 18, 2025Floor vote
Voted Nay on Do No Harm in Medicaid Act
Result: Passed
Feb 4, 2026Legislation
Cosponsored HR 1529
Pharmaceutical sector
Feb 5, 2026Legislation
Cosponsored HR 6842
Pharmaceutical sector
Feb 10, 2026Legislation
Cosponsored HR 5434
Pharmaceutical sector
Feb 11, 2026Legislation
Cosponsored HRES 1058
Pharmaceutical sector
Feb 18, 2026Trade
Bought up to $15,000 of RARE
Mar 3, 2026Legislation
Cosponsored HR 3757
Pharmaceutical sector
Mar 9, 2026Disclosure
Disclosed the trade
Public filing
Apr 16, 2026Floor vote
Voted Nay on Expressing support for tax policies that support working families.
Result: Passed
May 15, 2026Committee
Committee on Armed Services hearing
Department of the Army Fiscal Year 2027 Budget Request

Source: U.S. House Clerk (disclosures-clerk.house.gov)

Get an alert the moment Gilbert Ray Cisneros Jr. files the next one

Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.

Get filing alerts See all of Jr.'s trades